Frequency of anemia in patients presenting with ulcerative colitis
Keywords:
ulcerative colitis, anemia, frequencyAbstract
Introduction: Anemia appears to be the most common extra intestinal manifestation of inflammatory bowel disease and has been associated with a wide range of complications such as impaired quality of life, an increased rate of hospital admissions and even mortality. Objective: To determine the frequency of anemia in patients presenting with ulcerative colitis. Material and methods;This Cross Sectional Study was conducted in the Department of Gastroenterology, ATH, Abbottabad from 20th September 2020 to 20th March 2021. A total of 109 patients of both gender with ulcerative colitis were included in the study. Venous blood was collected from all patients in sodium EDTA tube by a 3rd year resident and was immediately sent to hospital laboratory. Hemoglobin < 11 g/dL was recorded as anemia and noted. Results: Age range in this study was from 18 to 60 years with mean age of 41.550±6.56 years, mean duration of complain was 9.862±2.57 months and mean weight was 80.091±7.60 Kg. Male patients were 63.3% and females were 36.7%. Anemia was observed in 14.7% Patients presenting with ulcerative colitis. Conclusion: In conclusion, we found a high incidence and prevalence of anaemia in patients presenting with ulcerative colitis.
Downloads
References
Gisbert JP, Chaparro M. Clinical usefulness of proteomics in inflammatory bowel disease: a comprehensive review. J Crohns Colitis. 2019;13(3):374-84.
Jackson B, De Cruz P. Algorithms to facilitate shared decision-making for the management of mild-to-moderate ulcerative colitis. Expert Rev Gastroenterol Hepatol. 2018;12(11):1079-100.
Spiceland CM, Lodhia N. Endoscopy in inflammatory bowel disease: role in diagnosis, management, and treatment. World J Gastroenterol. 2018;24(35):4014-20.
Ashton JJ, Ennis S, Beattie RM. Early-onset paediatric inflammatory bowel disease. Lancet Child Adolesc Health. 2017;1(2):147-58.
Liu CY, Polk DB. Microbiomes through the looking glass: what do UC? Cell Host Microbe. 2018;24(4):472-4.
Tulewicz-Marti E, Moniuszko A, Rydzewska G. Management of anemia in inflammatory bowel disease: a challenge in everyday clinical practice. Prz Gastroenterol. 2017;12(4):239-43.
Eriksson C, Henriksson I, Brus O. Incidence, prevalence and clinical outcome of anaemia in inflammatory bowel disease: a population-based cohort study. Aliment Pharmacol Ther. 2018;48(6):638-45.
Woźniak M, Barańska M, Małecka-Panas E, Talar-Wojnarowska R. The prevalence, characteristics, and determinants of anaemia in newly diagnosed patients with inflammatory bowel disease. Prz Gastroenterol. 2019;14(1):39-47.
Wilson A, Reyes E, Ofman J. Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. Am J Med. 2004;116(Suppl 7A):44 49.
Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther. 2006;24:1507 1523
Stein J, Bager P, Befrits R, et al. Anaemia management in patients with inflammatory bowel disease: routine practice across nine European countries. Eur J Gastroenterol Hepatol. 2013;25:1456 1463
Filmann N, Rey J, Schneeweiss S, et al. Prevalence of anemia in inflammatory bowel diseases in European countries: a systematic review and individual patient data meta analysis. Inflamm Bowel Dis. 2014;20:936 945.
Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser. 1968;405:5 37
Hoivik ML, Reinisch W, Cvancarova M, Moum B. Anaemia in inflammatory bowel disease: a population based 10 year follow up. Aliment Pharmacol Ther. 2014;39:69 76.
Rejler M, Tholstrup J, Andersson Gare B, Spangeus A. Low prevalence of anemia in inflammatory bowel disease: a population based study in Sweden. Scand J Gastroenterol. 2012;47:937 942
Lindgren S, Wikman O, Befrits R, et al. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: a randomized, controlled, evaluator blind, multicentre study. Scand J Gastroenterol. 2009;44:838 845.
Schroder O, Mickisch O, Seidler U, et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease–a randomized, controlled, open label, multicenter study. Am J Gastroenterol. 2005;100:2503 2509
Rampton DS, Goodhand JR, Joshi NM, et al. Oral iron treatment response and predictors in anaemic adolescents and adults with IBD: a prospective controlled open label trial. Journal of Crohn's & colitis. 2017;11:706 715.
de Silva AD, Tsironi E, Feakins RM, et al. Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial. Aliment Pharmacol Ther. 2005;22:1097 1105.
Bager P, Befrits R, Wikman O, et al. High burden of iron deficiency and different types of anemia in inflammatory bowel disease outpatients in Scandinavia: a longitudinal 2 year follow up study. Scand J Gastroenterol. 2013;48:1286 1293.
Weiss G, Gasche C. Pathogenesis and treatment of anemia in inflammatory bowel disease. Haematologica. 2010;95:175 178.
Bergamaschi G, Di Sabatino A, Albertini R, et al. Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti tumor necrosis factor alpha treatment. Haematologica. 2010;95:199 205.
Burisch J, Vegh Z, Katsanos KH, et al. Occurrence of Anaemia in the First Year of Inflammatory Bowel Disease in a European Population based Inception Cohort An ECCO EpiCom Study. Journal of Crohn's & colitis. 2017;11:1213 1222.
Sjöberg D, Holmström T, Larsson M, Nielsen AL, Holmquist L, Rönnblom A. Anemia in a population based IBD cohort (ICURE): still high prevalence after 1 year, especially among pediatric patients. Inflamm Bowel Dis. 2014;20:2266 2270.
Voegtlin M, Vavricka SR, Schoepfer AM, et al. Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross sectional study in patients from private practices and university hospitals. Journal of Crohn's & colitis. 2010;4:642 648.
Danese S, Hoffman C, Vel S, et al. Anaemia from a patient perspective in inflammatory bowel disease: results from the European Federation of Crohn's and Ulcerative Colitis Association's online survey. Eur J Gastroenterol Hepatol. 2014;26:1385 1391.
Gasche C, Lomer MC, Cavill I, Weiss G. Iron, anaemia, and inflammatory bowel diseases. Gut. 2004;53:1190 1197.
Bager P, Befrits R, Wikman O, et al. The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia. Scand J Gastroenterol. 2011;46:304 309.
Published
How to Cite
Issue
Section
Copyright (c) 2023 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
